Stock Price
1,338.90
Daily Change
3.80 0.28%
Monthly
4.13%
Yearly
23.68%
Q2 Forecast
1,306.83

Aurobindo Pharma reported INR9.1B in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Cipla INR 6.76B 6.75B Dec/2025
Divis Laboratories Ltd INR 5.83B 1.06B Dec/2025
Dr.Reddys Laboratories INR 12.1B 2.27B Dec/2025
Hindustan Unilever INR 66.07B 39.22B Dec/2025
Sun Pharmaceuticals INR 33.69B 2.51B Dec/2025
UPL INR 3.96B 1.57B Dec/2025